Michael Fumento’s work on explaining adult stem cells is stellar. Perhaps, that is because, of the many hats he wears, one is that of a science writer. In this article in the American Spectator, Fumento explains how the mistakes in Dr. Catherine Verfaillie’s paper that first identified the therapeutic potential of a type of bone marrow stem cell, is much ado about very little. Check it out. He explains it all in a way that even I can understand.
One final note: There is nothing wrong with the American Spectator. But it is a vivid illustration of the mainstream media’s intense bias about the stem cell issue that pieces such as Fumento’s, which is accurate, fair, and timely, would almost never be published in more widely read news organs such as the New York Times or Newsweek. In fact, the Times leaped at the chance to expose Verfaillie’s mistake, but did not report the pluripotent potential of stem cells found in amniotic fluid or the story of Dr. Carlos Lima’s restoring feeling to spinal cord injury patients with adult stem cells.
Time is short, so I’ll be direct: FIRST THINGS needs you. And we need you by December 31 at 11:59 p.m., when the clock will strike zero. Give now at supportfirstthings.com.
First Things does not hesitate to call out what is bad. Today, there is much to call out. Yet our editors, authors, and readers like you share a greater purpose. And we are guided by a deeper, more enduring hope.
Your gift of $50, $100, or even $250 or more will bring this message of hope to many more people in the new year.
Make your gift now at supportfirstthings.com..
First Things needs you. I’m confident you’ll answer the call.
